For research use only. Not for therapeutic Use.
Rosnilimab is a humanized IgG1-κ antibody targeting to PD-1[1][2].
| Catalog Number | I040849 |
| CAS Number | 2412764-40-8 |
| Purity | ≥95% |
| Reference | [1]. Pattabiraman, et al. Synthetic IL-7 and IL-7-anti-PD-1 antibody immunocytokines for cancer therapy. World Intellectual Property Organization, WO2023281484 A1 2023-01-12. [2]. Rosnilimab. IMGT/mAb-DB. |
